Health and Healthcare

Amgen : AMGN

All Amgen Articles

717 Articles

Chris Lange | Dec 12, 2017 at 10:10 AM EST

Major Biotechs See Rising Tide in Short Interest

The November 30 short interest data have been compared with the previous report, and short interest in most of the…

Lee Jackson | Dec 11, 2017 at 9:50 AM EST

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

One industry that could be a huge winner from tax reform, and may surprise some investors, is biotechnology, especially for…

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

Chris Lange | Nov 10, 2017 at 10:40 AM EST

Short Sellers Grow More Selective on Major Biotechs

The October 31 short interest data have been compared with the previous report, and short interest in the selected biotech…

Lee Jackson | Nov 10, 2017 at 10:15 AM EST

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Merrill Lynch points to five companies that, in their words, should be key players in the young but growing biosimilar…

Jon C. Ogg | Nov 1, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Abercrombie, Amgen, Electronic Arts, GM, Goldcorp, Shopify, 3D Systems, Under Armour and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Abercrombie & Fitch, Amgen, Electronic Arts, General Motors,…

Chris Lange | Oct 25, 2017 at 10:40 AM EDT

Short Sellers Chase Biotechs Higher

The October 13 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Chris Lange | Oct 11, 2017 at 11:35 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Oct 4, 2017 at 1:30 PM EDT

What CytomX Gets From Its Huge Amgen Collaboration

CytomX Therapeutics shares made a solid gain in Wednesday’s session following announcement of a strategic collaboration with Amgen in immuno-oncology.

Chris Lange | Sep 28, 2017 at 12:45 PM EDT

AbbVie and Amgen Reach Global Resolution of Humira

AbbVie shares made a handy gain on Thursday after it was announced that the company resolved its Humira patent disputes…

Chris Lange | Sep 27, 2017 at 10:25 AM EDT

Short Sellers Hike Bets in Major Biotechs

The September 15 short interest data have been compared with the previous report, and short interest in all the selected…

Chris Lange | Sep 13, 2017 at 8:55 AM EDT

Short Sellers Hike Bets in Major Biotechs

The August 31 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Sep 13, 2017 at 7:15 AM EDT

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown…

Chris Lange | Aug 25, 2017 at 10:10 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest moves in the selected…

1 … 18 19 20 21 22 … 48

Amgen : AMGN

All Amgen Articles

Major Biotechs See Rising Tide in Short Interest

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Short Sellers Grow More Selective on Major Biotechs

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Abercrombie, Amgen, Electronic Arts, GM, Goldcorp, Shopify, 3D Systems, Under Armour and More

Short Sellers Chase Biotechs Higher

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Short Sellers Grow More Selective on Major Biotechs

What CytomX Gets From Its Huge Amgen Collaboration

AbbVie and Amgen Reach Global Resolution of Humira

Short Sellers Hike Bets in Major Biotechs

Short Sellers Hike Bets in Major Biotechs

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent’s Share or Watch It Get Split Among the Aunts and Uncles

Arizonans Don't Retire in Scottsdale. Here's Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Amgen : AMGN

All Amgen Articles

Major Biotechs See Rising Tide in Short Interest

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Short Sellers Grow More Selective on Major Biotechs

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Abercrombie, Amgen, Electronic Arts, GM, Goldcorp, Shopify, 3D Systems, Under Armour and More

Short Sellers Chase Biotechs Higher

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Short Sellers Grow More Selective on Major Biotechs

What CytomX Gets From Its Huge Amgen Collaboration

AbbVie and Amgen Reach Global Resolution of Humira

Short Sellers Hike Bets in Major Biotechs

Short Sellers Hike Bets in Major Biotechs

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent’s Share or Watch It Get Split Among the Aunts and Uncles

Featured Reads

Arizonans Don't Retire in Scottsdale. Here's Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.